Support Action for Americans With ALS
Accelerating Access to Critical Therapies for ALS Act
The Accelerating Access to Critical Therapies for ALS Act will build new pathways to fund early access to ALS investigational therapies, and increase research on and development of interventions for rare neurodegenerative diseases through a new Food and Drug Administration (FDA) research grants program.
